Skip to main content

Advertisement

Log in

High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin’s lymphoma in China

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

We retrospectively analyzed a large study to investigate the association of hepatitis B virus (HBV) with aggressive B cell non-Hodgkin’s lymphoma (aggressive B-NHL) in China, where HBV is endemic. HBV was present in 39 aggressive B-NHL patients (10.46%), 13 indolent B-NHL patients (5.09%), 12 multiple myeloma (MM) patients (3.67%), and 5 solitary plasmacytoma (SP) patients (6.67%). HBV infection was significantly associated with increased risks for aggressive B-NHL (P < 0.01). HBV seems to have a very important role in the pathogenesis of aggressive B-NHL in China.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Yu MW, Lin CL, Liu Chun J et al (2017) Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B: A large cohort study[J]. Gastroenterology 153(4):1006–1017

  2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, AlMazroa MA, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Abdulhak AB, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, de Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FGR, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Memish ZA, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KMV, Nasseri K, Norman P, O’Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA III, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, de León FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJL (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095–2128. https://doi.org/10.1016/S0140-6736(12)61728-0

    Article  PubMed  Google Scholar 

  3. Zhou YH, Wu C, Zhuang H (2009) Vaccination against hepatitis B: the Chinese experience. Chin Med J 122(1):98–102

    PubMed  Google Scholar 

  4. Coluccio C, Begini P, Marzano A, Pellicelli A, Imperatrice B, Anania G, Delle Fave G, Marignani M (2017) Hepatitis B in patients with hematological disease: an update. World J Hepatol 9(25):1043–1053. https://doi.org/10.4254/wjh.v9.i25.1043

    Article  PubMed  PubMed Central  Google Scholar 

  5. L.M.Morton, S. S. Wang, W. Cozen, et al. (2014) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr (48):130–144

  6. Ozoya OO, Chavez J, Sokol L et al (2017) Optimizing antiviral agents for hepatitis B management in malignant lymphomas. Ann Transl Med 5(3):39. https://doi.org/10.21037/atm.2016.12.25

    Article  PubMed  PubMed Central  Google Scholar 

  7. Chen J, Wang JM, Yang JM et al (2013) Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin’s lymphoma after chemotherapy. PLoS One 8(7):e69400. https://doi.org/10.1371/journal.pone.0069400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Deng LJ, Song YQ, Yong KH et al (2015) Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin. Oncotarget 6(28):25061–25073. https://doi.org/10.18632/oncotarget.4677

    Article  PubMed  PubMed Central  Google Scholar 

  9. Dalia S, Chavez J, Castillo JJ, Sokol L (2013) Hepatitis B infection increases the risk of non-Hodgkin’s lymphoma: a meta-analysis of observational studies. Leuk Res 37(9):1107–1115. https://doi.org/10.1016/j.leukres.2013.06.007

    Article  PubMed  Google Scholar 

  10. Becker N, Schnitzler P, Boffetta P, Brennan P, Foretova L, Maynadié M, Nieters A, Staines A, Benavente Y, Cocco P, de Sanjose S (2012) Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol 138(12):1993–2001. https://doi.org/10.1007/s00432-012-1279-y

    Article  PubMed  Google Scholar 

  11. Kang J, Cho JH, Suh CW, Lee DH, Oh HB, Sohn YH, Chi HS, Park CJ, Jang SS, Lee KH, Lee JH, Lee JH, Lee SW, Chung YH, Kim TH, Shin HR, Huh J (2011) High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hemotol 90(2):159–164. https://doi.org/10.1007/s00277-010-1055-5

    Article  Google Scholar 

  12. Marcucci F, Mele A (2011) Hepatitis viruses and NHL: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 117(6):1792–1798. https://doi.org/10.1182/blood-2010-06-275818

    Article  CAS  PubMed  Google Scholar 

  13. Lim ST, Fei G, Quek R, Lim LC, Lee LH, Yap SP, Loong S, Tao M (2007) The relationship of hepatitis B virus infection and non-Hodgkin’s lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 79(2):132–137. https://doi.org/10.1111/j.1600-0609.2007.00878.x

    Article  CAS  PubMed  Google Scholar 

  14. Marcucci F, Mele A, Spada E, Candido A, Bianco E, Pulsoni A, Chionne P, Madonna E, Cotichini R, Barbui A, de Renzo A, Dore F, Iannitto E, Liso V, Martino B, Montanaro M, Pagano L, Musto P, Rapicetta M (2006) High prevalence of hepatitis B virus infection in B-cell non-Hodgkin’s lymphoma. Haematologica 91(4):554–557

    PubMed  Google Scholar 

  15. Thumallapally N, Meshref A, Mousa M, Terjanian T (2017) Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. BMC Cancer 17(1):13. https://doi.org/10.1186/s12885-016-3015-5

    Article  PubMed  PubMed Central  Google Scholar 

  16. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y (2013) Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination. Vaccine 31(47):J21–J28. https://doi.org/10.1016/j.vaccine.2013.08.012

    Article  PubMed  Google Scholar 

  17. Engels EA, Cho ER, Jee SH (2010) Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 11:827–834

    Article  PubMed  PubMed Central  Google Scholar 

  18. Nath A, Agarwal R, Malhotra P, Varma S (2010) Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis. Intern Med J 40(9):633–641. https://doi.org/10.1111/j.1445-5994.2009.02060.x

    Article  CAS  PubMed  Google Scholar 

  19. Kleinstern G, Seir RA, Perlman R, Abdeen Z, Khatib A, Elyan H, Dann EJ, Kedmi M, Ellis M, Nagler A, Amir G, Ben Yehuda D, Safadi R, Paltiel O (2016) Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B. Haematologica 101(7):e303–e305. https://doi.org/10.3324/haematol.2016.144840

    Article  PubMed  PubMed Central  Google Scholar 

  20. Makvandi M (2016) Update on occult hepatitis B virus infection[J]. World J Gastroenterol 22(39):8720–8734. https://doi.org/10.3748/wjg.v22.i39.8720

  21. Wang KF, Yang H, He WJ et al (2017) Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study[J]. J Cancer 8(14): 2676–2683. https://doi.org/10.7150/jca.19665

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yizhuo Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, C., Xia, B., Ning, Q. et al. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin’s lymphoma in China. Ann Hematol 97, 453–457 (2018). https://doi.org/10.1007/s00277-017-3188-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3188-2

Keywords

Navigation